Immediate Impact
6 standout
Citing Papers
Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
2025 Standout
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
2024 Standout
Works of Heidi L. Moline being referenced
Medical Costs of Respiratory Syncytial Virus–Associated Hospitalizations and Emergency Department Visits in Children Aged Younger Than 5 Years: Observational Findings from the New Vaccine Surveillance Network, 2016-2019
2024
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Heidi L. Moline | 18 | 11 | 36 | 16 | 11 | 69 | |
| Patrícia Mouta Nunes de Oliveira | 23 | 3 | 29 | 28 | 10 | 72 | |
| Ian D. Jones | 18 | 3 | 55 | 5 | 11 | 177 | |
| John Barthelow Classen | 55 | 7 | 45 | 22 | 14 | 207 | |
| F. Fily | 55 | 6 | 49 | 30 | 10 | 178 | |
| James Robson | 32 | 8 | 53 | 29 | 12 | 179 | |
| Angela Aramburo | 48 | 21 | 24 | 20 | 10 | 172 | |
| Sirintip Sricharoenchai | 77 | 10 | 65 | 12 | 13 | 173 | |
| Walter P. Kennedy | 28 | 21 | 34 | 10 | 16 | 165 | |
| Konstantinos Karampatsas | 24 | 21 | 47 | 19 | 7 | 86 | |
| Carolina Rescigno | 27 | 3 | 61 | 9 | 12 | 113 |
All Works
Login with ORCID to disown or claim papers
Loading papers...